Literature DB >> 35950404

[Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion: A case report and literature review].

Y Y DU1, J Wang1, L He1, L N Ji1, X W Xu1,2.   

Abstract

We reported a pediatric case of Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) from Beijing Tsinghua Changgung Hospital. The clinical data were retrospectively analyzed and the related literature was reviewed. The clinical features, treatment and prognosis of the disease were summarized to improve recognition of Kawasaki disease complicated with MERS. A 7-year-old boy was diagnosed with Kawasaki disease due to continuous high fever for 6 d, accompanied by strawberry tongue, conjunctival congestion, erythema-like hyperemia rash, and cervical enlarged lymph nodes. And treatment was started with intravenous immunoglobulin (IVIG: 2 g/kg) and oral aspirin [40 mg/(kg·d)]. Twenty-four hours after the treatment of IVIG, the patient' s fever persisted and in addition he developed headache and drowsiness. His cranial magnetic resonance imaging (MRI) demonstrated a localized lesion in the splenium of the corpus callosum with high intensity signal on diffusion-weighted images (DWI) and T2-weighted, and low intensity signal on apparent diffusion coefficient (ADC) and T1-weighted. Based on these findings, he was diagnosed with MERS-complicated Kawasaki disease. Methylprednisolone [2 mg/(kg·d)] treatment was started intravenously, and within several hours he was afebrile and the neurological symptoms disappeared. A follow-up MRI was conducted after 1 week was normal. He was discharged without any neurological sequelae and coronary artery lesions. A total of 12 qualified foreign literature were retrieved, with no Chinese literature searched. Seventeen children were reported, the median age was 6.5 years (range: 1-14 years), among them 11 cases were children over 5 years old, and 4 cases were complicated with coronary artery lesions. All children had neurological symptoms, such as consciousness disorder, visual hallucination or convulsion. MRI conformed to MERS imaging changes. After active treatment, the neurological manifestations and radiological abnormalities completely disappeared, leaving no neurological sequelae. Kawasaki disease complicated with MERS had not been reported in China by now. Literature that identified Kawasaki disease complicated with MERS mostly occurred in children over 5 years old. Cranial MRI examination is helpful for early diagnosis. Timely treatment can reverse MERS in a short time, without neurological sequelae left.

Entities:  

Keywords:  Child; Mild encephalitis/encephalopathy with a reversible splenial lesion; Mucocutaneous lymph node syndrome

Mesh:

Substances:

Year:  2022        PMID: 35950404      PMCID: PMC9385509     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  21 in total

1.  Kawasaki disease-associated MERS: pathological insights from SPECT findings.

Authors:  Tatsuharu Sato; Yoko Ushiroda; Toshifumi Oyama; Akiko Nakatomi; Hideki Motomura; Hiroyuki Moriuchi
Journal:  Brain Dev       Date:  2011-10-22       Impact factor: 1.961

2.  Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Authors:  Tohru Kobayashi; Yoshinari Inoue; Kazuo Takeuchi; Yasunori Okada; Kazushi Tamura; Takeshi Tomomasa; Tomio Kobayashi; Akihiro Morikawa
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

3.  Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Rie Miyata; Naoyuki Tanuma; Masaharu Hayashi; Takuji Imamura; Jun-ichi Takanashi; Rieko Nagata; Akihisa Okumura; Hirohumi Kashii; Sunao Tomita; Satoko Kumada; Masaya Kubota
Journal:  Brain Dev       Date:  2011-05-14       Impact factor: 1.961

4.  Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.

Authors: 
Journal:  J Rheumatol       Date:  2019-12       Impact factor: 4.666

5.  Hyponatremia in Kawasaki disease.

Authors:  Toru Watanabe; Yuki Abe; Seiichi Sato; Yumiko Uehara; Kanju Ikeno; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

6.  Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis.

Authors:  Amy Ka; Philip Britton; Christopher Troedson; Richard Webster; Peter Procopis; Joanne Ging; Yew Wee Chua; Adam Buckmaster; Nicholas Wood; Cheryl Jones; Russell C Dale
Journal:  Eur J Paediatr Neurol       Date:  2015-02-13       Impact factor: 3.140

Review 7.  Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations.

Authors:  Jay Starkey; Nobuo Kobayashi; Yuji Numaguchi; Toshio Moritani
Journal:  Radiographics       Date:  2017-02-06       Impact factor: 5.333

8.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

9.  Prognostic impact of vascular leakage in acute Kawasaki disease.

Authors:  Masaru Terai; Takafumi Honda; Kumi Yasukawa; Kouji Higashi; Hiromichi Hamada; Yoichi Kohno
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

10.  Cerebral hypoperfusion during acute Kawasaki disease.

Authors:  T Ichiyama; M Nishikawa; T Hayashi; M Koga; N Tashiro; S Furukawa
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.